- Published at
- by manilatimes.net
neutral
neutral
News for Equillium, Inc. (0A4D.L)
- Published at
- by gurufocus.com
positivepositiveEquillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat se- Published at
- by gurufocus.com
positivepositiveEquillium (EQ) Faces Setback as FDA Declines Accelerated Approval for Itolizumab | EQ Stock News
Equillium Inc. (EQ) recently encountered a significant hurdle as the U.S. Food and Drug Administration (FDA) decided against an accelerated approval pathway for- Published at
- by gurufocus.com
positivepositiveEquillium Announces Feedback from the U.S. Food and Drug Administration
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat se- Published at
- by gurufocus.com
positivepositiveEquillium (EQ) Faces FDA Setback for Itolizumab in Graft-versus-Host Disease Treatment | EQ Stock News
Equillium Inc. (EQ) recently received feedback from the U.S. Food and Drug Administration (FDA) regarding its efforts to fast-track the approval of itolizumab,- Published at
- by benzinga.com
positivepositiveGold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results - Dermata Therapeutics (NASDAQ:DRMA), Auddia (NASDAQ:AUUD)
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 90 points on Thursday. The Dow traded down 0.23% to 42,358.68 while th...- Published at
- by benzinga.com
mixedmixedNasdaq Down Over 100 Points; US Initial Jobless Claims Fall - Dermata Therapeutics (NASDAQ:DRMA), Auddia (NASDAQ:AUUD)
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. Following the market opening Thursday, the Dow trade...- Published at
- by investing.com
neutralneutralEquillium CFO Jason Keyes sells $6,500 in stock By Investing.com
Equillium CFO Jason Keyes sells $6,500 in stock- Published at
- by investing.com
neutralneutralEquillium stock touches 52-week low at $0.6 amid market challenges By Investing.com
Equillium stock touches 52-week low at $0.6 amid market challenges- Published at
- by zacks.com
positivepositiveEquillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth
Equillium (EQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.- Published at
- by investing.com
positivepositiveEquillium shares downgraded to hold from buy By Investing.com
Equillium shares downgraded to hold from buy- Published at
- by benzinga.com
mixedmixedWhy Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Carvana (NYSE:CVNA)
Shares of Carvana Co. CVNA rose in today's pre-market trading after the company reported better-than-expected third-quarter financial results. Carvana reported...- Published at
- by gurufocus.com
neutralneutralInsider Sale: Sr. Vice President and COO Christine Zedelmayer Sells 15,000 Shares of Equillium Inc (EQ)
Christine Zedelmayer, Sr. Vice President and Chief Operating Officer of Equillium Inc (EQ), executed a sale of 15,000 shares of the company on October 28, 2024.- Published at
- by investing.com
mixedmixedEquillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer By Investing.com
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer- Published at
- by investing.com
mixedmixedEquillium CFO Jason Keyes sells $8,100 in company stock By Investing.com
Equillium CFO Jason Keyes sells $8,100 in company stock- Published at
- by investing.com
positivepositiveEquillium executive sells $32,985 in stock By Investing.com
Equillium executive sells $32,985 in stock- Published at
- by globenewswire.com
positivepositiveVivtex Enters New Research Agreement with Equillium to
Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide therapyEquillium...- Published at
- by benzinga.com
mixedmixedWhy Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Core & Main (NYSE:CNM)
Loading... Loading... Shares of Core & Main Inc CNM fell sharply during Tuesday's session after the company reported mixed first-quarter financial results. Co...- Published at
- by benzinga.com
mixedmixedWhy Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - Westport Fuel Systems (NASDAQ:WPRT)
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.- Published at
- by marketscreener.com
mixedmixedVivani Medical Appoints Daniel Bradbury to its Board of Directors
Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin...